IBDEI0EG ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6970,1,4,0)
 ;;=4^592.0
 ;;^UTILITY(U,$J,358.3,6970,1,5,0)
 ;;=5^Renal Calculi
 ;;^UTILITY(U,$J,358.3,6970,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,6971,0)
 ;;=403.91^^55^575^50
 ;;^UTILITY(U,$J,358.3,6971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6971,1,4,0)
 ;;=4^403.91
 ;;^UTILITY(U,$J,358.3,6971,1,5,0)
 ;;=5^Renal Failure, Chronic Hypertensive
 ;;^UTILITY(U,$J,358.3,6971,2)
 ;;=^269610
 ;;^UTILITY(U,$J,358.3,6972,0)
 ;;=586.^^55^575^53
 ;;^UTILITY(U,$J,358.3,6972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6972,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,6972,1,5,0)
 ;;=5^Uremia
 ;;^UTILITY(U,$J,358.3,6972,2)
 ;;=Uremia^104733
 ;;^UTILITY(U,$J,358.3,6973,0)
 ;;=599.0^^55^575^65
 ;;^UTILITY(U,$J,358.3,6973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6973,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,6973,1,5,0)
 ;;=5^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,6973,2)
 ;;=Urinary Tract Infection^124436
 ;;^UTILITY(U,$J,358.3,6974,0)
 ;;=275.42^^55^575^28
 ;;^UTILITY(U,$J,358.3,6974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6974,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,6974,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,6974,2)
 ;;=Hypercalcemia^59932
 ;;^UTILITY(U,$J,358.3,6975,0)
 ;;=275.41^^55^575^31
 ;;^UTILITY(U,$J,358.3,6975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6975,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,6975,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,6975,2)
 ;;=Hypocalcemia^60542
 ;;^UTILITY(U,$J,358.3,6976,0)
 ;;=276.7^^55^575^29
 ;;^UTILITY(U,$J,358.3,6976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6976,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,6976,1,5,0)
 ;;=5^Hyperkalemia/Hyperpotassemia
 ;;^UTILITY(U,$J,358.3,6976,2)
 ;;=Hyperkalemia/Hyperpotassemia^60042
 ;;^UTILITY(U,$J,358.3,6977,0)
 ;;=276.8^^55^575^32
 ;;^UTILITY(U,$J,358.3,6977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6977,1,4,0)
 ;;=4^276.8
 ;;^UTILITY(U,$J,358.3,6977,1,5,0)
 ;;=5^Hypokalemia/Hypopotassemia
 ;;^UTILITY(U,$J,358.3,6977,2)
 ;;=Hypokalemia/Hypopotassemia^60611
 ;;^UTILITY(U,$J,358.3,6978,0)
 ;;=275.2^^55^575^26
 ;;^UTILITY(U,$J,358.3,6978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6978,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,6978,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,6978,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,6979,0)
 ;;=276.0^^55^575^30
 ;;^UTILITY(U,$J,358.3,6979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6979,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,6979,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,6979,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,6980,0)
 ;;=276.1^^55^575^33
 ;;^UTILITY(U,$J,358.3,6980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6980,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,6980,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,6980,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,6981,0)
 ;;=275.3^^55^575^27
 ;;^UTILITY(U,$J,358.3,6981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6981,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,6981,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,6981,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,6982,0)
 ;;=250.40^^55^575^16
 ;;^UTILITY(U,$J,358.3,6982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6982,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,6982,1,5,0)
 ;;=5^DM type II with Nephropathy
 ;;^UTILITY(U,$J,358.3,6982,2)
 ;;=DM type II with Nephropathy^267837^583.81
 ;;^UTILITY(U,$J,358.3,6983,0)
 ;;=790.93^^55^575^1
 ;;^UTILITY(U,$J,358.3,6983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6983,1,4,0)
 ;;=4^790.93
 ;;^UTILITY(U,$J,358.3,6983,1,5,0)
 ;;=5^Abnormal PSA
